의료진 정보

성필수
부교수
간암,간이식,간경변,간염,알콜성간질환,지방성간질환

의료진 | 진료과 | 전문진료분야 | 오 전 | 오 후 | 진료예약 |
---|---|---|---|---|---|
성필수 | 소화기내과 | 간암,간이식,간경변,간염,알콜성간질환,지방성간질환 | 수,목 | 화,목,금 | ![]() |
- [학력 및 자격 사항]
- 2001 ~ 2007 Graduation from College of Medicine, The Catholic University of Korea
- 2001 ~ 2007 가톨릭의대 의학 학사
- 2009 ~ 2011 (M.S) The Catholic University of Korea
- 2009 ~ 2011 가톨릭의대 의학 석사
- 2012 ~ 2016 (M.D., Ph.D.) KAIST
- 2012 ~ 2016 한국과학기술원 (KAIST) 이학 박사
- [경력및 연수]
- 2016 ~ 2020 임상강사, 임상진료조교수, 서울성모병원 소화기내과
- 2020 ~ 2022 조교수, 서울성모병원 소화기내과
- 2022 ~ 부교수, 서울성모병원 소화기내과
- [수상 경력]
- 2021 ~ 2020 교육부 우수연구성과 50선 선정
- 2007 ~ 한국보건의료인국가시험원장상 (71회 의사국가고시 전국수석)
- 2007 ~ 가톨릭대학교 총장상 (가톨릭의대 48회 수석졸)
- 2012 ~ 2012 내과학교실 특별공로상 (55회 내과 전문의 수석)
- 2021 ~ 대한간암학회 학술상 (기초중개연구)
- 2021 ~ 과기부 한국연구재단 이공학개인기초연구 연구비 수혜 (우수신진)
- 2019 ~ 대한 간학회 우수 구연상 (총 6회, 2013, 2015, 2016, 2017, 2019, 2020)
- 2020 ~ 대웅제약 학술연구비 수혜
- 2020 ~ 가톨릭의대 총동문회 학술연구비 수혜
- 2019 ~ 대한간암학회 최우수구연상
- 2019 ~ 교육부 한국연구재단 이공학개인기초연구 연구비 수혜 (창의도전)
- 2019 ~ 가톹릭의대 내과학교실 학술연구비 수혜
- 2018 ~ 서울성모병원 개인기초연구비(2016), 기술사업화연구비 2회 (2018, 2020) 수혜
- 2017 ~ 과기부 한국연구재단 이공학개인기초연구 연구비 수혜 (기본)
- 2017 ~ 세계간암학회(ILCA) 젊은연구자상
- 2012 ~ 한국연구재단 글로벌박사펠로우쉽 연구비 수혜
- 2012 ~ 대한 간학회 최우수 논문상 (2회, 2012, 2018)
- 2016 ~ KAIST 생명과학기술대학 우수 박사학위 논문상
- 2015 ~ 아시아태평양 간학회 우수 구연상 (2회, 2015, 2017)
- 2013 ~ 미국간학회 우수 포스터상 (2회, 2013, 2020)
- Amiodarone hepatotoxicity 2012
- Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells 2014
- CD8+ T-Cell responses in acute hepatitis C virus infection 2014
- Inactivation efficiency of DNA and RNA viruses during chitin-to-chitosan conversion. 2015
- Activation of human natural killer cells by the soluble form of cellular prion protein 2015
- Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness 2015
- Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection. 2015
- Prolonged silencing of diacylglycerol acyltransferase‐1 induces a dedifferentiated phenotype in human liver cells 2016
- IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection 2017
- Long-Term Outcome of Liver Resection Versus Transplantation for Hepatocellular Carcinoma in a Region Where Living Donation is a Main Source. 2017
- CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner 2017
- Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications 2018
- Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling 2018
- 18F-fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment 2018
- Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8(+) T Cells in Patients Considered Immune Tolerant 2019
- Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma 2019
- Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma 2019
- Early Onset Polymorphic Post-transplant Lymphoproliferative Disease Mimicking a Solitary Necrotizing Abscess in a Graft Liver 2019
- IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses 2020
- A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis. 2020
- A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis! 2020
- EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1 2020
- microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis 2020
- microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and de novo Lipogenesis 2020
- IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses 2020
- Targeted Next-Generation Sequencing of Plasma Cell-Free DNA in Korean Patients with Hepatocellular Carcinoma 2021
- Targeted Next-Generation Sequencing of Plasma Cell-Free DNA in Korean Patients with Hepatocellular Carcinoma 2021
- A newly developed subcutaneous nodule 15 years after liver transplantation 2021
- Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant 2021